To Örebro University

Enhancing lupus outcomes by means of biology beyond overt clinical features, exemplified in an in-depth investigation of the effects of circadian rhythm disruption 2024 (English)In: Lupus Science and Medicine, E-ISSN 2053-8790, Vol. 11, no 1, article id e001215Article in journal, Letter (Refereed) Published

Place, publisher, year, edition, pages

BMJ Publishing Group Ltd, 2024. Vol. 11, no 1, article id e001215

Keywords [en]

Antirheumatic Agents, Lupus Erythematosus, Systemic, Lupus Nephritis, Therapeutics

National Category

Clinical Medicine

Identifiers

URN: urn:nbn:se:oru:diva-113076DOI: 10.1136/lupus-2024-001215ISI: 001201871300001PubMedID: 38599671Scopus ID: 2-s2.0-85190102919OAI: oai:DiVA.org:oru-113076DiVA, id: diva2:1850655

Funder

Swedish Rheumatism Association, R-969696King Gustaf V Jubilee Fund, FAI-2020-0741Swedish Society of Medicine, SLS-974449Nyckelfonden, OLL-974804Region Stockholm, FoUI-955483Karolinska Institute

Note

IP is supported by grants from the Swedish Rheumatism Association (R-969696), King Gustaf V’s 80-year Foundation (FAI-2020-0741), Swedish Society of Medicine (SLS-974449), Nyckelfonden (OLL-974804), Professor Nanna Svartz Foundation (2021-00436), Ulla and Roland Gustafsson Foundation (2021-26), Region Stockholm (FoUI-955483), and Karolinska Institutet.

Available from: 2024-04-11 Created: 2024-04-11 Last updated: 2025-02-18Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Parodis, Ioannis

Search in DiVA

By author/editor

Parodis, Ioannis

By organisation

School of Medical Sciences

In the same journal

Lupus Science and Medicine

On the subject

Clinical Medicine

Search outside of DiVA

GoogleGoogle ScholarTotal: 19 hits